Dopamine d2 Receptor Antikörper (AA 194-421)
-
- Target Alle Dopamine d2 Receptor (DRD2) Antikörper anzeigen
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
-
Bindungsspezifität
- AA 194-421
-
Reaktivität
- Ratte
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser Dopamine d2 Receptor Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), Immunohistochemistry (IHC), Immunoprecipitation (IP), Immunocytochemistry (ICC)
- Verwendungszweck
- Polyclonal Antibody to Dopamine Receptor D2 (DRD2)
- Spezifität
- The antibody is a rabbit polyclonal antibody raised against DRD2. It has been selected for its ability to recognize DRD2 in immunohistochemical staining and western blotting.
- Kreuzreaktivität
- Human, Maus
- Aufreinigung
- Antigen-specific affinity chromatography followed by Protein A affinity chromatography
- Immunogen
- Recombinant Dopamine Receptor D2 (DRD2) corresdonding to Ser194~Ala421 with N-terminal His Tag
- Isotyp
- IgG
-
-
- Applikationshinweise
-
Western blotting: 0.5-2 μg/mL Immunohistochemistry: 5-20 μg/mL Immunocytochemistry: 5-20 μg/mL Optimal working dilutions must be determined by end user.
- Kommentare
-
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37°C for 48h, and no obvious degradation and precipitation were observed. The loss rate is less than 5% within the expiration date under appropriate storage condition.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- 0.01M PBS, pH 7.4, containing 0.05 % Proclin-300, 50 % glycerol.
- Konservierungsmittel
- ProClin
- Vorsichtsmaßnahmen
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- 4 °C,-20 °C
- Informationen zur Lagerung
- Store at 4°C for frequent use. Stored at -20°C in a manual defrost freezer for two year without detectable loss of activity. Avoid repeated freeze-thaw cycles.
- Haltbarkeit
- 24 months
-
- Target
- Dopamine d2 Receptor (DRD2) (Dopamine Receptor D2 (DRD2))
- Andere Bezeichnung
- Dopamine Receptor D2 (DRD2 Produkte)
- Synonyme
- D2DR antikoerper, D2R antikoerper, drd2b antikoerper, d2r2 antikoerper, Drd-2 antikoerper, d2dr antikoerper, d2r antikoerper, drd2 antikoerper, drd2-B antikoerper, DRD2 antikoerper, D2 antikoerper, CG18741 antikoerper, CG7569 antikoerper, DAMB antikoerper, DDR2 antikoerper, DOPR2 antikoerper, DOPR99B antikoerper, Dar2 antikoerper, Dmel\\CG18741 antikoerper, DopD1 antikoerper, DopR99B antikoerper, DopRII antikoerper, dopamine receptor D2 antikoerper, dopamine receptor D2 like antikoerper, dopamine receptor D2 L homeolog antikoerper, dopamine receptor D2 S homeolog antikoerper, Dopamine 1-like receptor 2 antikoerper, DRD2 antikoerper, drd2l antikoerper, drd2 antikoerper, Drd2 antikoerper, drd2.L antikoerper, drd2.S antikoerper, Dop1R2 antikoerper
- Hintergrund
- DR-D2, D2DR, D2R
- Pathways
- Positive Regulation of Peptide Hormone Secretion, Negative Regulation of Hormone Secretion, cAMP Metabolic Process, Inositol Metabolic Process, Regulation of G-Protein Coupled Receptor Protein Signaling, Feeding Behaviour, Negative Regulation of Transporter Activity, Regulation of long-term Neuronal Synaptic Plasticity
-